Marlborough Nano Cap Growth B
|Bid Price||GBX 113.34||Offer Price||GBX 125.05|
|Mid Price||-||Day Change||GBX +0.36 (0.32%)|
|Price Date||2 Dec 2016||Crown Rating|
|Shares Class||Inc.||Yield||0.00 %|
|Total Expense Ratio||0.00||Fund Size||100,489,703.55|
|Launch Date||31/10/2013||Standard Initial Charge (%)||5.25|
|Annual Management Charge (%)||1.00||Sector||IMA UK Equity Income|
|Min Investment (£)||100,000.00||Total Expense Ratio (%)||0.00|
|ISIN||GB00BF2ZTZ50||Min TopUp (£)||1,000.00|
The investment objective of the Marlborough Nano-Cap Growth Fund is to seek to provide capital growth in excess of that achieved by the FTSE Small Cap Index (excluding investment companies) over the long term. The Fund will aim to achieve its investment objective by investing primarily in the shares of small, UK listed equities having a market capitalisation of £100 million or less at the time of investment. The Fund will be actively managed.
After starting his career in 1969 as an analyst with James Capel, Giles joined Management Agency and Music as a private fund manager in 1974 before founding Hargreave Investment Management in 1986. Giles then merged Hargreave Investment Management with Hargreave Hale & Co, a provincial stockbroking firm controlled by other members of his family, in 1988. As Chief Executive, Giles chairs the weekly investment committee meetings in which the team reviews existing and potential investments for all the funds.